A confidential conversation can help you sort out safer next steps
Practical considerations for getting started If you and your healthcare provider decide that GLP-1 microdosing is worth exploring for your autoimmune condition, here are the practical details that matter
In clinical studies of microneedle patches, researchers are testing doses to match the absorption levels of injectable medications
Semaglutide has advanced to registration phase clinical trials
in patients with T2DM (38) found that continuous GLP-1 administration via a subcutaneous pump to raise serum GLP-1 levels from a mean of 9.7 pM at baseline to 282 pM over 6 weeks significantly reduced plasma glucose concentrations, improved glycated hemoglobin, and enhanced insulin sensitivity and -cell function compared to placebo, with no significant limiting side effects reported
It blocks tyrosinase, the enzyme responsible for melanin production, leading to lighter skin